Successful switch to aripiprazole after induction of hyperprolactinemia by ziprasidone: a case report.
Anghelescu
Ion
I
Wolf
Jürgen
J
D000328:Adult; D000553:Ambulatory Care; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D000068180:Aripiprazole; D005260:Female; D006801:Humans; D006966:Hyperprolactinemia / Q000139:chemically induced* / Q000517:prevention & control; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use*; D011388:Prolactin / Q000097:blood; D015363:Quinolones / Q000627:therapeutic use*; D012563:Schizophrenia, Paranoid / Q000097:blood / Q000188:drug therapy* / Q000523:psychology; D020018:Sexual Dysfunctions, Psychological / Q000139:chemically induced / Q000517:prevention & control; D013844:Thiazoles / Q000009:adverse effects* / Q000627:therapeutic use
D014150:Antipsychotic Agents; D010879:Piperazines; D015363:Quinolones; D013844:Thiazoles; C092292:ziprasidone; D000068180:Aripiprazole; D011388:Prolactin